Detroit — Detroit, Michigan

Detroit is a clinical research site located in Detroit, Michigan, United States 48202.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Detroit has participated in 12 clinical trials with 2 currently active.

Therapeutic areas: Clostridium Difficile Infection Recurrence, Metastatic Castration-Resistant Prostate Cancer, Clostridium Difficile Infection (CDI).

Sponsors: Finch Research and Development LLC., Corcept Therapeutics, Rebiotix Inc..

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Detroit?

Detroit has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Detroit conducted?

Detroit has 12 clinical trials on record, with 2 currently active. Their work covers Clostridium Difficile Infection Recurrence, Metastatic Castration-Resistant Prostate Cancer, Clostridium Difficile Infection (CDI).

Is Detroit accredited by Crixeo Health?

Yes — Detroit holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Detroit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.